Hydroxyzine Pamoate
NDC 76420-920, Hydroxyzine Pamoate, capsule, from Asclemed USA, Inc..
- Product NDC
- 76420-920
- Status
- Listed
- Labeler
- Asclemed USA, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA088496
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76420-920 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROXYZINE PAMOATE25 mg/1
Pharmacologic classes
Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76420-920-01 | 76420092001 | 100 CAPSULE in 1 BOTTLE (76420-920-01) |
| 76420-920-05 | 76420092005 | 500 CAPSULE in 1 BOTTLE (76420-920-05) |
| 76420-920-30 | 76420092030 | 30 CAPSULE in 1 BOTTLE (76420-920-30) |
| 76420-920-60 | 76420092060 | 60 CAPSULE in 1 BOTTLE (76420-920-60) |
| 76420-920-90 | 76420092090 | 90 CAPSULE in 1 BOTTLE (76420-920-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/82187031-779e-47bc-943c-eb1a1ef30a7a
Use it
Look up 76420-920 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76420-920 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76420-920. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.